research papers
The bound structure of a novel HIV-1 capsid-assembly inhibitor describes a unique inhibitor-binding site on the capsid N-terminal domain. Moreover, use of this inhibitor as a crystallization tool greatly improved the success rate of capsid N-terminal domain ternary cocrystallizations via compound-mediated synthetic dimerization.